Popularity of Zyn and other nicotine pouch brands among U.S. adolescents, young adults, and adults in 2021.

Autor: Liu J; REACH Lab, Division of Adolescent Medicine, Department of Pediatrics, Stanford University., Halpern-Felsher B; REACH Lab, Division of Adolescent Medicine, Department of Pediatrics, Stanford University. Electronic address: bonnie.halpernfelsher@stanford.edu.
Jazyk: angličtina
Zdroj: Preventive medicine [Prev Med] 2024 Aug; Vol. 185, pp. 108068. Date of Electronic Publication: 2024 Jul 14.
DOI: 10.1016/j.ypmed.2024.108068
Abstrakt: Objective: This study identifies brands of nicotine pouches used in 2021, just before the surge in popularity of Zyn use.
Methods: We conducted a national, cross-sectional online survey of a general U.S. population (November to December 2021; N = 6131; age 13-40) via Qualtrics panels. Descriptive analyses and chi-squared tests (alpha = 0.05) were performed to assess ever and past-30-day use of nicotine pouch brands across adolescents (13-20), young adults (21-24), and adults (25-40), and to assess frequency of popular brands used among peers.
Results: The top brands ever used were Zyn (overall: 30.9%; adolescents: 31.9%; young adults: 33.2%; adults: 28.3%) and Lyft (overall: 28.8%; adolescents: 28.4%; young adults: 32.9%; adults: 26.3%), with no differences in ever-use by age group (p's > 0.095). The top brands used in the past-30-days were Zyn (overall: 26.4%; adolescents: 24.5%; young adults: 24.3%; adults: 30.0%) and Rush (overall: 24.2%; adolescents: 21.0%; young adults: 22.7%; adults: 28.6%). Adults (vs. adolescents, young adults) were more likely to report past-30-day use of Lyft (p = 0.004). Participants indicated Zyn (18.5%) and Lyft (18.2%) to be the most popular brands among peers.
Conclusions: Even in 2021, Zyn was the most popular brand of nicotine pouches. Findings will help regulate and reduce impact of marketing of Zyn.
Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr. Halpern-Felsher is a paid expert scientist in some litigation against e-cigarette companies and an unpaid scientific advisor and expert witness regarding some tobacco-related policies. She is also the Founder and Executive Director of the Tobacco Prevention Toolkit and the Cannabis Awareness and Prevention Toolkit. Dr. Liu has no conflicts of interest to disclose.
(Copyright © 2024 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: